Title : Profile of nintedanib in the treatment of solid tumors: the evidence to date.

Pub. Date : 2015

PMID : 26677336






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Novel antiangiogenic agents, such as sunitinib, sorafenib, pazopanib, or vandetanib that target additional proangiogenic signaling pathways beyond VEGF, have also been approved for the treatment of various malignant diseases. vandetanib vascular endothelial growth factor A Homo sapiens